Does LINAGLIPTIN Cause Mobility decreased? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Mobility decreased have been filed in association with LINAGLIPTIN (Linagliptin and metformin hydrochloride). This represents 0.3% of all adverse event reports for LINAGLIPTIN.
21
Reports of Mobility decreased with LINAGLIPTIN
0.3%
of all LINAGLIPTIN reports
0
Deaths
19
Hospitalizations
How Dangerous Is Mobility decreased From LINAGLIPTIN?
Of the 21 reports, 19 (90.5%) required hospitalization, and 1 (4.8%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LINAGLIPTIN. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does LINAGLIPTIN Cause?
Blood glucose increased (804)
Dyspnoea (571)
Dizziness (529)
Pruritus (527)
Nausea (525)
Diarrhoea (509)
Vomiting (465)
Fatigue (464)
Malaise (457)
Arthralgia (446)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which LINAGLIPTIN Alternatives Have Lower Mobility decreased Risk?
LINAGLIPTIN vs LINAGLIPTIN\METFORMIN
LINAGLIPTIN vs LINCOMYCIN
LINAGLIPTIN vs LINEZOLID
LINAGLIPTIN vs LINZESS
LINAGLIPTIN vs LIORESAL